Protein Kinase C Epsilon Inhibitors to Treat Pain

Abstract

We propose to develop potent and selective inhibitors of the enzyme PKCepsilon as therapeutics that can be administered orally or intravenously for the treatment of acute and chronic pain. This application addresses the FY17 PRMRP Topic Area Non-Opioid Pain Management.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2020
Accession Number
AD1116941

Entities

People

  • Jon D. Levine

Organizations

  • University of California Regents

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Analgesia
  • Biomedical Research
  • California
  • Chemistry
  • Department Of Defense
  • Governments
  • Humanities
  • Information Operations
  • Inhibitors
  • Law
  • Lead Compounds
  • Local Governments
  • Maryland
  • Medical Personnel
  • Neuroplasticity
  • Opioids
  • Pain
  • Pain Management
  • Patent Applications
  • Patents
  • Professional Development
  • Students
  • Therapy
  • Training
  • Universities

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Prostate Cancer Biology.
  • Toxicology/Environmental Toxicology